SMTL ID : 4otq.1

Crystal structure of BTK kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x 2V2: 1-{5-[3-(7-tert-butyl-4-oxoquinazolin-3(4H)-yl)-2-methylphenyl]-1-methyl-2-oxo-1,2-dihydropyridin-3-yl}-3-methylurea(Non-covalent)

2V2.1: 24 residues within 4Å: Chain A: L.32, G.33, T.34, G.35, Q.36, F.37, V.40, A.52, K.54, T.98, E.99, Y.100, M.101, A.102, G.104, D.145, N.150, L.152, S.162, D.163, L.166, S.167, V.170, Y.175 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:F.37, A:F.37, A:V.40, A:V.40, A:V.40, A:D.163, A:L.166, A:V.170, A:Y.175 Hydrogen bonds: A:M.101, A:M.101, A:M.101 Water bridges: A:G.35, A:Q.36, A:N.150

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 6 residues within 4Å: Chain A: R.144, P.184, W.187, S.188, F.198, S.202 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.203 Water bridges: A:R.144, A:R.144 DMS.3: 6 residues within 4Å: Chain A: R.144, S.167, Y.175, T.176, F.183, F.198 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lou, Y. et al., Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. J.Med.Chem. (2015)

Release Date

2014-05-14

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence